- Home
- BTAI vs KOSS Comparison
BTAI vs KOSS Comparison
Compare BTAI & KOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BTAI | KOSS |
|---|---|---|
| Founded | 2017 | 1953 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Consumer Electronics/Appliances |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.8M | 39.3M |
| IPO Year | 2018 | 1994 |
Fundamental Metrics
Financial Performance| Metric | BTAI | KOSS |
|---|---|---|
| Price | $0.87 | $3.96 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $23.00 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 17.3K |
| Earning Date | 05-08-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 75.63 | 10.00 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $12,624,170.00 |
| Revenue This Year | $197.82 | N/A |
| Revenue Next Year | $910.15 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 2.93 |
| 52 Week Low | $0.74 | $3.50 |
| 52 Week High | $8.08 | $8.59 |
Technical Indicators
Market Signals| Indicator | BTAI | KOSS |
|---|---|---|
| Relative Strength Index (RSI) | 37.23 | 49.77 |
| Support Level | $0.74 | $3.79 |
| Resistance Level | $1.37 | $4.18 |
| Average True Range (ATR) | 0.13 | 0.15 |
| MACD | -0.04 | 0.00 |
| Stochastic Oscillator | 17.11 | 51.26 |
Price Performance
Historical ComparisonAbout BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About KOSS Koss Corporation
Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-canceling headphones. The majority of the firm's revenue is derived from sales of stereo headphones. The Company also sells products to distributors for resale to school systems, and directly to other manufacturers for inclusion with their own products.